Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance

International Journal of Clinical Practice

Volumn 61, Issue 11, 2007, Pages 1798-1804

  Julius, U ^a   Dittrich, M ^a   Pietzsch, J ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GLUCOSE INTOLERANCE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTHROPOMETRY; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; REGRESSION ANALYSIS; SEX FACTORS; SYNDROME;

EID: 35348843962     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01507.x     Document Type: Article

References (41)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 97.
2. Koba S, Hirano T, Ito Y et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 2006 189 : 206 14.
3. Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 2005 54 : 227 34.
4. St-Pierre AC, Cantin B, Dagenais GR et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005 25 : 553 9.
5. Gazi IF, Tsimihodimos V, Tselepis AD, Elisaf M, Mikhailidis DP. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther 2007 7 : 53 72.
6. Rizzo M, Berneis K. Small, dense low-density-lipoproteins and the metabolic syndrome. Diabetes Metab Res Rev 2006 23 : 14 20.
7. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003 31 : 1066 9.
8. Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma. Clin Chem 2005 51 : 2264 73.
9. Pietzsch J, Subat S, Nitzsche S et al. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta 1995 1254 : 77 88.
10. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994 5 : 395 403.
11. Krauss R, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol 1992 3 : 377 83.
12. Skoglund-Andersson C, Tang R, Bond MG et al. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol 1999 19 : 2422 30.
13. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005 366 : 1059 62.
14. Rizzo M, Barbagallo CM, Severino M et al. Low-density-lipoprotein peak particle size in a Mediterranean population. Eur J Clin Invest 2003 33 : 126 33.
15. Haffner SM, D'Agostino RJ, Goff D et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol 1999 19 : 2234 40.
16. Haffner SM, Mykkanen L, Robbins D et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 1995 38 : 1328 36.
17. Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism 2006 55 : 885 91.
18. Sandhofer A, Kaser S, Ritsch A et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 2006 14 : 812 8.
19. Garin MC, Kalix B, Morabia A, James RW. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 2005 90 : 2264 9.
20. Hokanson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk 1996 3 : 213 9.
21. Sarwar N, Danesh J, Eiriksdottir G et al. Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007 115 : 450 8.
22. Okumura K, Matsui H, Kawakami K et al. Modulation of LDL particle size after an oral glucose load is associated with insulin levels. Clin Chim Acta 1998 276 : 143 55.
23. Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999 25 : 199 211.
24. Festa A. Small, dense low density lipoprotein (LDL) and the insulin resistance syndrome (IRS). Clin Lab 2001 47 : 111 8.
25. Yoshino G, Hirano T, Kazumi T. Treatment of small dense LDL. J Atheroscler Thromb 2002 9 : 266 75.
26. Gazi IF, Filippatos TD, Tsimihodimos V et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 2006 41 : 647 54.
27. Slyper AH, Zvereva S, Schectman G et al. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism 1997 46 : 1275 80.
28. Mykkänen L, Haffner S, Rainwater D et al. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 1997 17 : 1447 53.
29. Ambrosch A, Muhlen I, Kopf D et al. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 1998 21 : 2077 84.
30. Rainwater DL. Lipoprotein correlates of LDL particle size. Atherosclerosis 2000 148 : 151 8.
31. Kang HS, Gutin B, Barbeau P, Litaker MS, Allison J, Le NA. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord 2002 26 : 1030 5.
32. Tsunoda F, Koba S, Hirano T et al. Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction. Circ J 2004 68 : 1165 72.
33. Takayanagi N, Onuma T, Kato S, Nishiyama K, Nomiyama T, Kawamori R. Association between LDL particle size and postprandial increase of remnant-like particles in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2004 66 : 245 52.
34. Blackburn P, Cote M, Lamarche B et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 2003 52 : 1379 86.
35. Koba S, Hirano T, Murayama S et al. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 2003 170 : 131 40.
36. Lee W, Min WK, Chun S et al. Low-density lipoprotein subclass and its correlating factors in diabetics. Clin Biochem 2003 36 : 657 61.
37. Toledo FG, Sniderman AD, Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 2006 29 : 1845 50.
38. Friedlander Y, Kidron M, Caslake M et al. Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000 148 : 141 9.
39. Leren TP, Ose L, Hamsten A, Karpe F. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000 20 : 1784 8.
40. Juo SH, Han Z, Smith JD et al. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 2000 20 : 1316 22.
41. Tan KC, Shiu SW, Wong Y. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus. Eur J Clin Invest 2003 33 : 301 6.